Determination of Risk Factors Associated With Isolation of Linezolid-Resistant Strains of Vancomycin-Resistant Enterococcus
- 1 December 2007
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 28 (12) , 1382-1388
Abstract
Objective.: To identify independent risk factors associated with isolation of linezolid-resistant, vancomycin-resistant Enterococcus (VRE).Design.: A retrospective, case-case-control study.Setting.: A tertiary care, academic medical center.Methods.: VRE isolates from clinical cultures were retrospectively analyzed for linezolid resistance during our 18-month study period. Clinical data were obtained from electronic patient records, and the risk factors associated with isolation of linezolid-resistant VRE were determined by comparison of 2 case groups with a control group.Results.: A total of 20% of the VRE isolates analyzed during the study period were linezolid resistant, and resistant isolates were most commonly recovered from the urine (40% of resistant isolates). Risk factors found to be associated with isolation of linezolid-resistant VRE were peripheral vascular disease and/or the receipt of a solid organ transplant, total parenteral nutrition, piperacillin-tazobactam, and/or cefepime. Only 25% of patients from whom linezolid-resistant VRE was isolated had previous linezolid exposure, and in the multivariate model this was not found to be a risk factor associated with the isolation of linezolid-resistant VRE.Conclusions.: The results of this analysis suggest that there is horizontal transmission of linezolid-resistant VRE in our institution and highlight the need for improved infection control measures. Furthermore, the high incidence of linezolid-resistant VRE demands a reassessment of our empirical antibiotic selection for patients infected with VRE.Keywords
This publication has 23 references indexed in Scilit:
- Nosocomial Spread of Enterococcus faecium Resistant to Vancomycin and Linezolid in a Tertiary Care Medical CenterJournal of Clinical Microbiology, 2006
- Emergence of Linezolid Resistance in the Vancomycin-Resistant Enterococcus faecium Multilocus Sequence Typing C1 Epidemic LineageJournal of Clinical Microbiology, 2006
- Oxazolidinone susceptibility patterns in 2004: report from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nationsJournal of Antimicrobial Chemotherapy, 2005
- Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case reportJournal of Antimicrobial Chemotherapy, 2005
- Surveillance of linezolid resistance in Germany, 2001–2002Clinical Microbiology and Infection, 2005
- Linezolid-Resistant, Vancomycin-Resistant Enterococcus faecium Infection in Patients without Prior Exposure to LinezolidClinical Infectious Diseases, 2003
- Risk Factors Associated with the Development of Infection with Linezolid‐ and Vancomycin‐ResistantEnterococcus faeciumClinical Infectious Diseases, 2002
- Editorial Commentary: Looking for Risk Factors for the Acquisition of Antibiotic Resistance: A 21st‐Century ApproachClinical Infectious Diseases, 2002
- Nosocomial Spread of Linezolid-Resistant, Vancomycin-ResistantEnterococcus faeciumNew England Journal of Medicine, 2002
- Risk Factors for Imipenem-Resistant Pseudomonas aeruginosa among Hospitalized PatientsClinical Infectious Diseases, 2002